These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34771496)

  • 21. Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter.
    Chen YJ; Huang CS; Phan NN; Lu TP; Liu CY; Huang CJ; Chiu JH; Tseng LM; Huang CC
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34387660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers.
    Dai X; Li Y; Bai Z; Tang XQ
    Sci Rep; 2015 Sep; 5():14499. PubMed ID: 26404658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.
    Chen C; Yuan JP; Wei W; Tu Y; Yao F; Yang XQ; Sun JZ; Sun SR; Li Y
    Int J Nanomedicine; 2014; 9():1039-48. PubMed ID: 24591826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
    Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
    Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
    Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of micrornas in molecular genetic breast cancer subtypes.
    Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
    Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response.
    Lips EH; Mulder L; de Ronde JJ; Mandjes IA; Koolen BB; Wessels LF; Rodenhuis S; Wesseling J
    Breast Cancer Res Treat; 2013 Jul; 140(1):63-71. PubMed ID: 23828499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer.
    Falato C; Schettini F; Pascual T; Brasó-Maristany F; Prat A
    Cancer Treat Rev; 2023 Jan; 112():102496. PubMed ID: 36563600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape.
    Yoon S; Won HS; Kang K; Qiu K; Park WJ; Ko YH
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance.
    Kim HK; Park KH; Kim Y; Park SE; Lee HS; Lim SW; Cho JH; Kim JY; Lee JE; Ahn JS; Im YH; Yu JH; Park YH
    Cancer Res Treat; 2019 Apr; 51(2):737-747. PubMed ID: 30189722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput proteomics of breast cancer subtypes: Biological characterization and multiple candidate biomarker panels to patients' stratification.
    Azevedo ALK; Gomig THB; Batista M; Marchini FK; Spautz CC; Rabinovich I; Sebastião APM; Oliveira JC; Gradia DF; Cavalli IJ; Ribeiro EMSF
    J Proteomics; 2023 Aug; 285():104955. PubMed ID: 37390896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taxonomy of breast cancer based on normal cell phenotype predicts outcome.
    Santagata S; Thakkar A; Ergonul A; Wang B; Woo T; Hu R; Harrell JC; McNamara G; Schwede M; Culhane AC; Kindelberger D; Rodig S; Richardson A; Schnitt SJ; Tamimi RM; Ince TA
    J Clin Invest; 2014 Feb; 124(2):859-70. PubMed ID: 24463450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic subtypes in Ethiopian breast cancer patient.
    Desalegn Z; Yohannes M; Porsch M; Stückrath K; Anberber E; Santos P; Bauer M; Addissie A; Bekuretsion Y; Assefa M; Worku Y; Taylor L; Abebe T; Kantelhardt EJ; Vetter M
    Breast Cancer Res Treat; 2022 Dec; 196(3):495-504. PubMed ID: 36282363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.
    Karthik GM; Rantalainen M; Stålhammar G; Lövrot J; Ullah I; Alkodsi A; Ma R; Wedlund L; Lindberg J; Frisell J; Bergh J; Hartman J
    BMC Cancer; 2017 Nov; 17(1):802. PubMed ID: 29187174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way.
    Eliyatkın N; Yalçın E; Zengel B; Aktaş S; Vardar E
    J Breast Health; 2015 Apr; 11(2):59-66. PubMed ID: 28331693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B.
    Raj-Kumar PK; Liu J; Hooke JA; Kovatich AJ; Kvecher L; Shriver CD; Hu H
    Sci Rep; 2019 May; 9(1):7956. PubMed ID: 31138829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.
    Gatza ML; Kung HN; Blackwell KL; Dewhirst MW; Marks JR; Chi JT
    Breast Cancer Res; 2011 Jun; 13(3):R62. PubMed ID: 21672245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression analysis of invasive breast carcinoma yields differential patterns in luminal subtypes of breast cancer.
    Abdelhafiz AS; Fouda MA; Elzefzafy NA; Taha II; Mohemmed OM; Alieldin NH; Toony I; Abdel Wahab AA; Farahat IG
    Ann Diagn Pathol; 2021 Dec; 55():151814. PubMed ID: 34517157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Expression Profiling in Early Breast Cancer-Patient Stratification Based on Molecular and Tumor Microenvironment Features.
    Munkácsy G; Santarpia L; Győrffy B
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.